Journal
MOLECULAR AND BIOCHEMICAL PARASITOLOGY
Volume 202, Issue 2, Pages 34-37Publisher
ELSEVIER
DOI: 10.1016/j.molbiopara.2015.09.007
Keywords
Leishmaniasis; Metabolism; Transamination; Aminotransferase; Substrate specificity; Drug design
Categories
Funding
- DAAD-UBA exchange program
Ask authors/readers for more resources
Leishmania species are early branching eukaryotic parasites that cause difficult-to-treat tissue-damaging diseases known as leishmaniases. As a hallmark of their parasitic lifestyle, Leishmaniae express a number of aminotransferases that are involved in important cellular processes and exhibit broader substrate specificity than their mammalian host's counterparts. Here, we have determined the crystal structure of the broad specificity aminotransferase from Leishmania mexicana (LmexBSAT) at 1.91 angstrom resolution. LmexBSAT is a homodimer and belongs to the alpha-branch of family-I aminotransferases. Despite the fact that the protein was crystallized in the absence of substrates and has lost the pyridoxal-5'-phosphate (PLP) cofactor during crystallization, the structure resembles the closed, ligand-bound form of related enzymes such as chicken cytosolic aspartate aminotransferase. Its broader substrate specificity seems to be rooted in increased flexibility of a substrate-binding arginine (R291) and the interactions of this residue with the N-terminus of the second chain of the dimer. (C) 2015 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available